Current and Emerging Issues in Wilsons Disease
NEJM 389:922-938, Roberts,E.A. & Schilsky, M.L., 2023
Wilson Disease Presenting with Catatonia
Neurol 96:e2781-e2782, Patel, R.A. & Bailey, M., 2021
A Middle-Aged Man with Progressive Gait Abnormalities
Neurol 97:e2423-e2428, Lin, J.,et al, 2021
Liver Transplantation as a Rescue Therapy for Severe Neurologic Forms of Wilson Disease
Neurol 94:e2189-e2202, Poujois, A.,et al, 2020
Muscle Stiffness, Gait Instability, and Liver Cirrhosis in Wilsons Disease
Lancet 396:990, Kronlage, C.,et al, 2020
MR Imaging of the Brain in Neurologic Wilson Disease
AJNR 40:178-183, Yu, X.-E.,et al, 2019
Wilson Disease
NIDDK Oct2018, , 2018
Wilson Disease
Yamada Textbook of Gastroenterology Chp 102, Metabolic Diseases of Liver, 6th Ed, Sunderam, S.S., & Sokol, R.J., 2016
Acquired Hepatocerebral Degeneration
Neurol 87:e144, Bateman, J.R. & Roque, D.A., 2016
Inherited Metabolic Diseases of the Nervous System, Hepatolenticular Degeneration (Wilson Disease)
Adams & Victors Principles of Neurology, Chp 37, pg 982, Ropper, A.H.,et al, 2014
Extensive Striatal, Cortical, and White Matter Brain MRI Abnormalities in Wilson Disease
Neurol 81:1557, Trocello, J.M.,et al, 2013
Differential Diagnosis of Bilateral Abnormalities of the Basal Ganglia and Thalamus
RadioGraphics 31:5-30, Hegde,A.N.,et al, 2011
Teaching NeuroImages: MRI Reversal in Wilson Disease With Trientine Treatment
Neurol 74:e72, Park,H.K., et al, 2010
Bilateral Thalamic Lesions
AJR 192:W53-W62, Smith,A.B.,et al, 2009
Wilson Disease: Description of 282 Patients Evaluated Over 3 Decades
Medicine 86:112-121, Taly,A.B., et al, 2007
Dystonia
NEJM 355:818-829, Tarsy,D. &Simon,D.K., 2006
Proton MR Spectroscopy in Wilson Disease: Analysis of 36 Cases
AJNR 26:1066-1071, Lucato,L.T.,et al, 2005
Clinical Correlation of Brain MRI and MRS Abnormalities in Patients with Wilson Disease
Neurol 63:638-643, Page,R.A.,et al, 2004
Treatment of Wilson Disease With Ammonium Tetrathiomolybdate, III. Initial Therapy in a Total of 55 Neurologically Affected Patients and Follow-up With Zinc Therapy
Arch Neurol 60:379-385, Brewer,G.J.,et al, 2003
Diffusion MR Imaging Changes Associated with Wilson Disease
AJNR 24:965-967, Sener,R.N., 2003
Effect of Liver Transplantation on Neurological Manifestations in Wilson Disease
ArchNeurol 57:384-386, Stracciari,A.,et al, 2000
Cerebral Injury After Cardiac Surgery,Identification of a Group of Extraordinary Risk
Stroke 30:514-522, Wolman,R.L.,et al, 1999
Oculogyric Crisis as an Initial Manifestation of Wilson's Disease
Neurol 52:714-715, Lee,M.S.,et al, 1999
Hyperintense Basal Ganglia on T1-Weighted MR Imaging
AJR 172:1109-1115, Lai,P.H.,et al, 1999
Diagnosis and Treatment of Wilson's Disease
Semin Neurol 19:261-270, Brewer,G.J.,et al, 1999
Wobbly Handwriting
Lancet 351:336, Rosario,M.A.F.,et al, 1998
Cerebral Manifestation of Wilson's Disease Successfully Treated with Liver Transplantation
Neurol 51:863-865, Bax,R.T.,et al, 1998
Atypical MRI Features of Wilson's Disease:High Signal in Globus Pallidus on T1-Weighted Images
Neuroradiology 39:171-174, Mochizuki,H.,et al, 1997
Neurologic Presentation of Wilson Disease without Kayser-Fleischer Rings
Neurol 46:1040-1043, Demirkiran,M.,et al, 1996
Misdiagnosis Revealed by Genetic Linkage Analysis in a Family with Wilson Disease
Neurol 46:1485-1486, Vidaud,D.,et al, 1996
Treatment of Wilson Disease with Ammonium Tetrathiomolybdate
Arch Neurol 53:1017-1025, Brewer,G.J.,et al, 1996
Wilson Disease:Findings at MR Imaging and CT of the Brain with Clinical Correlation
Radiology 198:531-536, van Wassenaer-van Hall,H.N.,et al, 1996
Cranial MR in Wilson Disease:Abnormal White Matter in Extrapyramidal and Pyramidal Tracts
AJNR 16:2021-2027, van Wassenaer-van Hall,H.N.,et al, 1995
MRI of the Brain in Wilson Disease:T2 Signal Loss Under Therapy
J Comput Assist Tomogr 19:635-638, Engelbrecht,V.,et al, 1995
Kayser-Fleischer Ring:Hepatolenticular Degeneration (Wilson's Disease)
Neurol 45:1261-1262, Finelli,P.F., 1995
Zinc-Induced Deterior in Wilson's Disease Aborted by Trtm with Penicillamine, Dimercaprol, & A Novel Zero Copper Diet
Arch Neurol 52:10-11, Walshe,J.M.,et al, 1995
Worsening of Neurologic Syndrome in Patients with Wilson's Disease with Initial Penicillamine Therapy
Arch Neurol 44:490-493, Brewer,G.J.,et al, 1994
Treatment of Wilson's Disease with Ammonium Tetrathiomolybdate
Arch Neurol 51:545-554, Brewer,G.J.,et al, 1994
Initial and Follow-up Brain MRI Findings and Correlation with the Clinical Course in Wilson's Disease
Neurol 44:1064-1068, Roh,J.K.,et al, 1994
Treatment with D-penicillamine Improves Dopamine D2-Receptor Binding and T2-Signal Intensity in de novo Wilson's Disease
Neurol 44:1079-1082, Schwarz,J.,et al, 1994
Development of Neurologic Symptoms in a Patient with Asymptomatic Wilson's Disease Treated with Penicillamine
Arch Neurol 51:304-305, Brewer,G.J.,et al, 1994
Correlation of Evoked Potential and MRI Findings in Wilson's Disease
Neurol 43:2059-2064, Selwa,L.M.,et al, 1993
Wilson's Disease:Evidence of Subgroups Derived from Clinical Findings and Brain Lesions
Neurol 43:120-124, Oder,W.,et al, 1993
Early Childhood Hepatocerebral Degeneration Misdiagnosed as Valproate Hepatotoxicity
Ann Neurol 32:767-775, Bicknese,A.R.,et al, 1992
Wilson Disease
Medicine 71:139-164, Brewer,G.J.&Yuzbasiyan-Gurkan,V., 1992
Wilson's Disease:Current Status
Am J Med 92:643-654, Yarze,J.C.,et al, 1992
Wilson's Disease:The Problem of Delayed Diagnosis
JNNP 55:692-696, Walshe,J.M.&Yealland,M., 1992
Prenatal Diagnosis of Wilson's Disease by Analysis of DNA Polymorphism
NEJM 327:57, Cossu,P.,et al, 1992
Atypical MR Presentation of Wilson Disease:A Possible Consequence of Paramagnetic Effect of Copper
Neuroradiology 34:222-224, Brugieres,P.,et al, 1992